unresectable, locally advanced Cholangiocarcinomas

DBCOND0128726Hepatobiliary Neoplasm

unresectable, locally advanced Cholangiocarcinomas is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Classified under: Hepatobiliary Neoplasm
Indicated drugs: Lirafugratinib
Pemigatinib

What you can answer from here — as of October 17, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for unresectable, locally advanced Cholangiocarcinomas share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account